Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Irvine

Showing results (521-530 of 679) with videos related to

Pageof 68
Sort By:
Journal of Immunological Methods|January 4, 2011
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesMargaret E Ackerman, Brian Moldt, Richard T Wyatt, et al.
Nature Communications|December 23, 2016
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyKristin L Griffiths, Mushtaq Ahmed, Shibali Das, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 7, 2023
Cholesterol-Amino-Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self-Amplifying RNA and Restoration of Spermatogenesis in Infertile MiceShi Du, Wenqing Li, Yuebao Zhang, et al.
ACS Central Science|April 29, 2024
Design of Cytotoxic T Cell Epitopes by Machine Learning of Human DegronsNicholas L Truex, Somesh Mohapatra, Mariane Melo, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Design of Cytotoxic T Cell Epitopes by Machine Learning of Human DegronsNicholas L Truex, Somesh Mohapatra, Mariane Melo, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2019
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into NanoparticlesMariane Melo, Ely Porter, Yuan Zhang, et al.
Nature Biotechnology|July 10, 2018
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryLi Tang, Yiran Zheng, Mariane Bandeira Melo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Pageof 68

Showing results (521-530 of 679) with videos related to

Sort By:
Pageof 68
Journal of Immunological Methods|January 4, 2011
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesMargaret E Ackerman, Brian Moldt, Richard T Wyatt, et al.
Nature Communications|December 23, 2016
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyKristin L Griffiths, Mushtaq Ahmed, Shibali Das, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 7, 2023
Cholesterol-Amino-Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self-Amplifying RNA and Restoration of Spermatogenesis in Infertile MiceShi Du, Wenqing Li, Yuebao Zhang, et al.
ACS Central Science|April 29, 2024
Design of Cytotoxic T Cell Epitopes by Machine Learning of Human DegronsNicholas L Truex, Somesh Mohapatra, Mariane Melo, et al.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Design of Cytotoxic T Cell Epitopes by Machine Learning of Human DegronsNicholas L Truex, Somesh Mohapatra, Mariane Melo, et al.
Nature Communications|November 25, 2017
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Chun Gwon Park, Christina A Hartl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2019
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into NanoparticlesMariane Melo, Ely Porter, Yuan Zhang, et al.
Nature Biotechnology|July 10, 2018
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryLi Tang, Yiran Zheng, Mariane Bandeira Melo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Pageof 68